508
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Current lipid-modifying agents

(Honorary Clinical Research Fellow) , &
 

Declaration of interest

AP Agouridis is supported by a grant from the Hellenic Atherosclerosis Society. TD Filippatos has given talks and attended conferences sponsored by Bristol-Myers Squibb, Pfizer, Lilly, Abbott, Amgen, AstraZeneca, Novartis, Vianex, Teva and MSD. N Katsiki has given talks, attended conferences and participated in trials sponsored by Novartis, Novo Nordisk, MSD, Winmedica and AstraZeneca. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.